{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:03:14Z","timestamp":1794654194141,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["DRF-2016-09-034"],"award-info":[{"award-number":["DRF-2016-09-034"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hospital Bristol NHS Foundation Trust"},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C8640\/A23385"],"award-info":[{"award-number":["C8640\/A23385"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41416-019-0458-x","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T23:03:48Z","timestamp":1556060628000},"page":"1045-1051","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Predictive value of inflammatory markers for cancer diagnosis in primary care: a prospective cohort study using electronic health records"],"prefix":"10.1038","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8177-6438","authenticated-orcid":false,"given":"Jessica","family":"Watson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Salisbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Whiting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willie","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,24]]},"reference":[{"key":"458_CR1","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/bjc.2014.606","volume":"112","author":"AS Ahmad","year":"2015","unstructured":"Ahmad, A. S., Ormiston-Smith, N. & Sasieni, P. D. Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960. Br. J. Cancer 112, 943\u2013947 (2015).","journal-title":"Br. J. Cancer"},{"key":"458_CR2","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1016\/j.ejca.2013.01.025","volume":"49","author":"ML Torring","year":"2013","unstructured":"Torring, M. L., Frydenberg, M., Hansen, R. P., Olesen, F. & Vedsted, P. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Eur. J. Cancer 49, 2187\u20132198 (2013).","journal-title":"Eur. J. Cancer"},{"issue":"Suppl 1","key":"458_CR3","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1038\/bjc.2015.49","volume":"112","author":"S McPhail","year":"2015","unstructured":"McPhail, S., Johnson, S., Greenberg, D., Peake, M. & Rous, B. Stage at diagnosis and early mortality from cancer in England. Br. J. Cancer 112(Suppl 1), S108\u2013S115 (2015).","journal-title":"Br. J. Cancer"},{"key":"458_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s12885-015-1424-5","volume":"15","author":"ML Ingeman","year":"2015","unstructured":"Ingeman, M. L., Christensen, M. B., Bro, F., Knudsen, S. T. & Vedsted, P. The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer\u2013a cross-sectional study of patient characteristics and cancer probability. BMC Cancer 15, 421 (2015).","journal-title":"BMC Cancer"},{"key":"458_CR5","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nrclinonc.2016.109","volume":"13","author":"W Hamilton","year":"2016","unstructured":"Hamilton, W., Walter, F. M., Rubin, G. & Neal, R. D. Improving early diagnosis of symptomatic cancer. Nat. Rev. Clin. Oncol. 13, 740\u2013749 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"458_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S1470-2045(15)00205-3","volume":"16","author":"G Rubin","year":"2015","unstructured":"Rubin, G., Berendsen, A., Crawford, S. M., Dommett, R., Earle, C., Emery, J. et al. The expanding role of primary care in cancer control. Lancet Oncol. 16, 1231\u20131272 (2015).","journal-title":"Lancet Oncol."},{"key":"458_CR7","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.3399\/bjgp16X683857","volume":"66","author":"J Watson","year":"2016","unstructured":"Watson, J., de Salis, I., Hamilton, W. & Salisbury, C. \u2018I\u2019m fishing really\u2019 - inflammatory marker testing in primary care: a qualitative study. Br. J. Gen. Pr. 66, e200\u2013e206 (2016).","journal-title":"Br. J. Gen. Pr."},{"key":"458_CR8","volume-title":"Suspected Cancer: Recognition and Referral [NG12].","author":"National Institute for Health and Care Excellence.","year":"2015","unstructured":"National Institute for Health and Care Excellence. Suspected Cancer: Recognition and Referral [NG12]. (NICE, London, 2015)."},{"key":"458_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3109\/10408363.2011.599831","volume":"48","author":"KH Allin","year":"2011","unstructured":"Allin, K. H. & Nordestgaard, B. G. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit. Rev. Clin. Lab. Sci. 48, 155\u2013170 (2011).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"458_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.7314\/APJCP.2013.14.1.243","volume":"14","author":"YZ Guo","year":"2013","unstructured":"Guo, Y. Z., Pan, L., Du, C. J., Ren, D. Q. & Xie, X. M. Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies. Asian Pac. J. Cancer Prev. 14, 243\u2013248 (2013).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"458_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10552-008-9212-z","volume":"20","author":"K Heikkila","year":"2009","unstructured":"Heikkila, K., Harris, R., Lowe, G., Rumley, A., Yarnell, J., Gallacher, J. et al. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control 20, 15\u201326 (2009).","journal-title":"Cancer Causes Control"},{"key":"458_CR12","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s10552-014-0445-8","volume":"25","author":"B Zhou","year":"2014","unstructured":"Zhou, B., Shu, B., Yang, J., Liu, J., Xi, T. & Xing, Y. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis. Cancer Causes Control 25, 1397\u20131405 (2014).","journal-title":"Cancer Causes Control"},{"key":"458_CR13","doi-asserted-by":"crossref","first-page":"64371","DOI":"10.18632\/oncotarget.11853","volume":"7","author":"X Zhang","year":"2016","unstructured":"Zhang, X., Liu, S. & Zhou, Y. Circulating levels of C-reactive protein, interleukin-6 and tumor necrosis factor-alpha and risk of colorectal adenomas: a meta-analysis. Oncotarget 7, 64371\u201364379 (2016).","journal-title":"Oncotarget"},{"key":"458_CR14","doi-asserted-by":"publisher","first-page":"e43075","DOI":"10.1371\/journal.pone.0043075","volume":"7","author":"B Zhou","year":"2012","unstructured":"Zhou, B., Liu, J., Wang, Z. M. & Xi, T. C-reactive protein, interleukin 6 and lung cancer risk: a meta-analysis. PloS ONE 7, e43075 (2012).","journal-title":"PloS ONE"},{"key":"458_CR15","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1158\/1055-9965.EPI-16-0120","volume":"25","author":"F Zeng","year":"2016","unstructured":"Zeng, F., Wei, H., Yeoh, E., Zhang, Z., Ren, Z. F., Colditz, G. A. et al. Inflammatory markers of CRP, IL6, TNFalpha, and soluble TNFR2 and the risk of ovarian cancer: a meta-analysis of prospective studies. Cancer Epidemiol., Biomark. Prev. 25, 1231\u20131239 (2016).","journal-title":"Cancer Epidemiol., Biomark. Prev."},{"key":"458_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep10508","volume":"5","author":"L Guo","year":"2015","unstructured":"Guo, L., Liu, S., Zhang, S., Chen, Q., Zhang, M., Quan, P. et al. C-reactive protein and risk of breast cancer: a systematic review and meta-analysis. Sci. Rep. 5, 10508 (2015).","journal-title":"Sci. Rep."},{"key":"458_CR17","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1158\/1055-9965.EPI-15-0324","volume":"24","author":"DS Chan","year":"2015","unstructured":"Chan, D. S., Bandera, E. V., Greenwood, D. C. & Norat, T. Circulating C-reactive protein and breast cancer risk - systematic literature review and meta-analysis of prospective cohort studies. Cancer Epidemiol., Biomark. Prev. 24, 1439\u20131449 (2015).","journal-title":"Cancer Epidemiol., Biomark. Prev."},{"key":"458_CR18","unstructured":"International Agency for Research on Cancer. GLOBOCAN 2012. http:\/\/globocan.iarc.fr ."},{"key":"458_CR19","first-page":"631","volume":"65","author":"E Shephard","year":"2014","unstructured":"Shephard, E., Neal, R., Rose, P., Walter, F., Litt, E. & Hamilton, W. Quantifying the risk of myeloma from symptoms reported in primary care patients: a large case-control study using electronic records. BJGP 65, 631 (2014).","journal-title":"BJGP"},{"key":"458_CR20","doi-asserted-by":"publisher","first-page":"e598","DOI":"10.3399\/bjgp12X654560","volume":"62","author":"E Shephard","year":"2012","unstructured":"Shephard, E., Stapley, S., Neal, R. D., Rose, P., Walter, F. & Hamilton, W. Clinical features of bladder cancer in primary care. Br. J. Gen. Pract. 62, e598\u2013e604 (2012).","journal-title":"Br. J. Gen. Pract."},{"key":"458_CR21","doi-asserted-by":"publisher","first-page":"e281","DOI":"10.3399\/bjgp15X684793","volume":"54","author":"EA Shephard","year":"2015","unstructured":"Shephard, E. A., Neal, R. D., Rose, P. W., Walter, F. M. & Hamilton, W. T. Quantifying the risk of non-Hodgkin lymphoma in symptomatic primary care patients aged\u2009\u2265\u200940 years: a large case\u2013control study using electronic records. BJGP 54, e281\u2013e288 (2015).","journal-title":"BJGP"},{"key":"458_CR22","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.3399\/bjgp15X684805","volume":"65","author":"EA Shephard","year":"2015","unstructured":"Shephard, E. A., Neal, R. D., Rose, P. W., Walter, F. M. & Hamilton, W. T. Quantifying the risk of Hodgkin lymphoma in symptomatic primary care patients aged\u2009\u2265\u200940 years: a case\u2013control study using electronic records. BJGP 65, e289\u2013e294 (2015).","journal-title":"BJGP"},{"key":"458_CR23","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.3399\/bjgp13X665215","volume":"63","author":"EA Shephard","year":"2013","unstructured":"Shephard, E. A., Stapley, S., Neal, R. D., Rose, P., Walter, F. M. & Hamilton, W. T. Clinical features of kidney cancer in primary care. Br. J. Gen. Pract. 63, e250\u2013e255 (2013).","journal-title":"Br. J. Gen. Pract."},{"key":"458_CR24","doi-asserted-by":"crossref","unstructured":"Watson, J., Nicholson, B. D., Hamilton, W. & Price, S. Identifying clinical features in primary care electronic health record studies: methods for codelist development. BMJ open 7, e019637 (2017).","DOI":"10.1136\/bmjopen-2017-019637"},{"key":"458_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3109\/02813438609013970","volume":"4","author":"BG Bentsen","year":"1986","unstructured":"Bentsen, B. G. International classification of primary care. Scand. J. Prim. Health Care 4, 43\u201350 (1986).","journal-title":"Scand. J. Prim. Health Care"},{"key":"458_CR26","first-page":"246280","volume":"2015","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Clin. Chem. 2015, 246280 (2015). clinchem.","journal-title":"Clin. Chem."},{"key":"458_CR27","doi-asserted-by":"publisher","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","volume":"12","author":"EI Benchimol","year":"2015","unstructured":"Benchimol, E. I., Smeeth, L., Guttmann, A., Harron, K., Moher, D., Petersen, I. et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 12, e1001885 (2015).","journal-title":"PLoS Med"},{"key":"458_CR28","unstructured":"Seed, P. DIAGT: Stata module to report summary statistics for diagnostic tests compared to true disease status. Statistical Software Components S423401, Boston College Department of Economics (2010)."},{"key":"458_CR29","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1001\/archinte.1986.00360200151024","volume":"146","author":"RM Fincher","year":"1986","unstructured":"Fincher, R. M. & Page, M. I. Clinical significance of extreme elevation of the erythrocyte sedimentation rate. Arch. Intern. Med. 146, 1581\u20131583 (1986).","journal-title":"Arch. Intern. Med."},{"key":"458_CR30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1742-1241.1996.tb09508.x","volume":"50","author":"G Lluberas-Acosta","year":"1996","unstructured":"Lluberas-Acosta, G. & Schumacher, H. R. Jr. Markedly elevated erythrocyte sedimentation rates: consideration of clinical implications in a hospital population. Br. J. Clin. Pr. 50, 138\u2013142 (1996).","journal-title":"Br. J. Clin. Pr."},{"key":"458_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/ijc.30732","volume":"141","author":"RLJ Hartmann","year":"2017","unstructured":"Hartmann, R. L. J., Martin, S., Anne, G., Steen, L., Peter, G., Kasper, I. et al. Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer. Int. J. Cancer 141, 191\u2013199 (2017).","journal-title":"Int. J. Cancer"},{"key":"458_CR32","doi-asserted-by":"publisher","first-page":"e586","DOI":"10.3399\/bjgp18X698357","volume":"68","author":"C Koshiaris","year":"2018","unstructured":"Koshiaris, C., Van den Bruel, A., Oke, J. L., Nicholson, B. D., Shephard, E., Braddick, M. et al. Early detection of multiple myeloma in primary care using blood tests: a case\u2013control study in primary care. BJGP 68, e586\u2013e593 (2018).","journal-title":"BJGP"},{"key":"458_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S1470-2045(13)70588-6","volume":"15","author":"J Banks","year":"2014","unstructured":"Banks, J., Hollinghurst, S., Bigwood, L., Peters, T. J., Walter, F. M. & Hamilton, W. Preferences for cancer investigation: a vignette-based study of primary-care attendees. Lancet Oncol. 15, 232\u2013240 (2014).","journal-title":"Lancet Oncol."},{"key":"458_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3399\/bjgp16X684457","volume":"66","author":"E Fuller","year":"2016","unstructured":"Fuller, E., Fitzgerald, K. & Hiom, S. Accelerate, coordinate, evaluate programme: a new approach to cancer diagnosis. BJGP 66, 176\u2013177 (2016).","journal-title":"BJGP"},{"key":"458_CR35","unstructured":"Office for National Statistics. Cancer Registration Statistics, England: 2014. Available at: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/bulletins\/cancerregistrationstatisticsengland\/2014#the-most-common-cancers-registered-were-breast-prostate-lung-and-colorectal-cancers ."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0458-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0458-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0458-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:48:49Z","timestamp":1694821729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-019-0458-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,24]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["458"],"URL":"https:\/\/doi.org\/10.1038\/s41416-019-0458-x","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,24]]},"assertion":[{"value":"14 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Independent Scientific Application Committee for MHRA database research (ISAC) protocol number 17_003. The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study is based on CPRD data and is subject to a full licence agreement which does not permit data sharing outside of the research team.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"This report is independent research arising from J.W.\u2019s Doctoral Research Fellowship (DRF-2016\u201309\u2013034) supported by the National Institute for Health Research. This research is linked to the CanTest Collaborative, which is funded by Cancer Research UK (C8640\/A23385), of which W.H. is co-lead. J.B., P.W., C.S. and J.W. were supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hospital Bristol NHS Foundation Trust. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, Health Education England or the Department of Health and Social Care.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}